Coya Therapeutics Files 8-K
Ticker: COYA · Form: 8-K · Filed: Oct 29, 2024 · CIK: 1835022
| Field | Detail |
|---|---|
| Company | Coya Therapeutics, Inc. (COYA) |
| Form Type | 8-K |
| Filed Date | Oct 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-K, disclosure
Related Tickers: COYA
TL;DR
COYA filed an 8-K, standard procedure, no major news.
AI Summary
Coya Therapeutics, Inc. filed an 8-K on October 29, 2024, to report on Regulation FD disclosures and financial statements. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form.
Why It Matters
This filing indicates Coya Therapeutics is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any specific new risks or material events.
Key Players & Entities
- Coya Therapeutics, Inc. (company) — Registrant
- 0001835022 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- DE (company) — State of Incorporation
- 1231 (company) — Fiscal Year End
- 001-41583 (company) — SEC File Number
- 241402731 (company) — Film Number
- October 29, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by Coya Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to provide financial statements and exhibits as required by the SEC.
When was this 8-K report filed by Coya Therapeutics, Inc.?
This 8-K report was filed on October 29, 2024.
What is Coya Therapeutics, Inc.'s state of incorporation?
Coya Therapeutics, Inc. is incorporated in Delaware (DE).
What is Coya Therapeutics, Inc.'s fiscal year end?
Coya Therapeutics, Inc.'s fiscal year ends on December 31 (1231).
What is the SEC file number for Coya Therapeutics, Inc.?
The SEC file number for Coya Therapeutics, Inc. is 001-41583.
Filing Stats: 570 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-10-29 08:00:55
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share COYA The Nasdaq Stock Mar
Filing Documents
- d821192d8k.htm (8-K) — 26KB
- d821192dex991.htm (EX-99.1) — 38KB
- d821192dex992.htm (EX-99.2) — 20KB
- g821192ex99_2s10g1.jpg (GRAPHIC) — 98KB
- g821192ex99_2s11g1.jpg (GRAPHIC) — 98KB
- g821192ex99_2s12g1.jpg (GRAPHIC) — 71KB
- g821192ex99_2s13g1.jpg (GRAPHIC) — 95KB
- g821192ex99_2s14g1.jpg (GRAPHIC) — 95KB
- g821192ex99_2s15g1.jpg (GRAPHIC) — 83KB
- g821192ex99_2s16g1.jpg (GRAPHIC) — 113KB
- g821192ex99_2s1g1.jpg (GRAPHIC) — 87KB
- g821192ex99_2s2g1.jpg (GRAPHIC) — 236KB
- g821192ex99_2s3g1.jpg (GRAPHIC) — 165KB
- g821192ex99_2s4g1.jpg (GRAPHIC) — 57KB
- g821192ex99_2s5g1.jpg (GRAPHIC) — 120KB
- g821192ex99_2s6g1.jpg (GRAPHIC) — 89KB
- g821192ex99_2s7g1.jpg (GRAPHIC) — 83KB
- g821192ex99_2s8g1.jpg (GRAPHIC) — 98KB
- g821192ex99_2s9g1.jpg (GRAPHIC) — 104KB
- 0001193125-24-246171.txt ( ) — 2561KB
- coya-20241029.xsd (EX-101.SCH) — 3KB
- coya-20241029_lab.xml (EX-101.LAB) — 18KB
- coya-20241029_pre.xml (EX-101.PRE) — 11KB
- d821192d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated October 29, 2024. 99.2 Investor Presentation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COYA THERAPEUTICS, INC. Date: October 29, 2024 By: /s/ Howard Berman Howard Berman Chief Executive Officer